Patents Assigned to Ann Arbor, Michigan Corporation
  • Methods of treating skin conditions using inhibitors of the CD2/LFA-3 interaction
    Publication number: 20040136987
    Abstract: Methods of using inhibitors of the CD2/LFA-3 interaction in treating skin conditions characterized by increased T cell activation and abnormal antigen presentation in the dermis and epidermis in mammals, including humans. Such conditions include psoriasis, UV damage, e.g., photoaging, atopic dermatitis, cutaneous T cell lymphoma such as mycosis fungoides, allergic and irritant contact dermatitis, lichen planus, alopecia areata, pyoderma gangrenosum, vitiligo, ocular cicatricial pemphigoid, and urticaria.
    Type: Application
    Filed: February 13, 2004
    Publication date: July 15, 2004
    Applicants: Biogen, Inc., a Massachusetts Corporation, The Regents of the University of Michigan, Ann Arbor, Michigan Corporation
    Inventors: Barbara P. Wallner, Kevin D. Cooper